NEW YORK, June 28 - Entigen has hired Denise Gilbert, a former executive at Incyte and Affymax, as the company's new CEO, Entigen announced Thursday.

As CEO, Gilbert will work on marketing Entigen's technology platform and expanding the business beyond its traditional focus on bioinformatics. The company has yet to disclose specifics on its new direction.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.